AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 251: F1029-F1035, 1986;
0363-6127/86 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mene, P.
Right arrow Articles by Dunn, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mene, P.
Right arrow Articles by Dunn, M. J.

AJP - Renal Physiology, Vol 251, Issue 6 1029-F1035, Copyright © 1986 by American Physiological Society

ARTICLES

Contractile effects of TxA2 and endoperoxide analogues on cultured rat glomerular mesangial cells

P. Mene and M. J. Dunn

Vasoconstrictor metabolites of arachidonic acid (AA) affect renal hemodynamics in various disease models. Since mesangial contraction could be involved in the glomerular response to vasoconstrictors, we studied the effects of thromboxane A2 (TxA2), synthesized by sheep platelet microsomes, and of two stable prostaglandin (PG) endoperoxide analogues (END), U-44069 and U-46619, on the morphology of cultured rat mesangial cells. Computer-assisted image analysis microscopy was employed to measure cross-sectional area (CSA) of individual cells during 40-min incubations with the agonists. Both END induced a dose-dependent increase of contracting cells (U-44069, 1 pM, 14.2%; 1 nM, 25.0%; 1 microM, 34.4%; maximum CSA decrease, 16.6 +/- 2.9%; U-46619, 1 pM, 11.4%; 1 nM, 25.6%; 1 microM, 37.2%; maximum CSA decrease, 23.6 +/- 2.2%). TxA2 contracted 30.1% of the cells, with a maximum CSA decrease of 20.5 +/- 2.4%. The TxA2-receptor antagonists EP 092 (EP) and SQ 27,427 (SQ) significantly (P less than 0.05) reduced the number of cells contracting in response to U-44069 (+EP 7.3%, +SQ 10.8%) or U-46619 (+EP 14.2%, +SQ 11.1%), and eliminated TxA2-induced contraction. END also stimulated mesangial immunoreactive prostaglandin E2 (PGE2) synthesis (U-44069, 1 nM, from 2.17 +/- 0.62 to 4.36 +/- 1.0; U-46619, 1 nM, from 2.09 +/- 0.64 to 5.05 +/- 1.04, ng X mg protein-1 X 15 min-1 +/- SE). These results suggest that mesangial contraction, with resulting reduction of filtration surface area, may contribute to the effects of TxA2 and endoperoxides on glomerular hemodynamics.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
C. S. Wilcox and W. J. Welch
Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II
Am J Physiol Renal Physiol, March 1, 2003; 284(3): F525 - F531.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
T. M. Coffman, R. F. Spurney, R. B. Mannon, and R. Levenson
Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells
Am J Physiol Renal Physiol, August 1, 1998; 275(2): F262 - F269.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online